Pricing for new drugs lacks transparency
2014-12-09
(Press-News.org) The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal of the Royal Society of Medicine, the authors of an essay on market-access agreements for anti-cancer drugs, say that while the underlying strategy is to help reduce the likelihood of health systems paying for treatments that turn out not to be cost-effective, the agreements can also be seen as an opportunistic way for pharmaceutical manufacturers to keep official prices high.
The authors of the essay, from University College London and the Mario Negri Institute for Pharmacological Research in Milan, conducted a comparative analysis of market-access agreements in oncology in the English and Italian health systems. Dr Livio Garattini, of the Mario Negri Institute, said: "England and Italy were the first countries to introduce market-access agreements on specific drugs almost a decade ago and our aim was to assess the experiences of both countries."
There are two types of market-access agreements. Financial-based schemes, favoured by the English NHS, focus on the budget impact of a new drug and consist of price/dose discounts. Performance-based schemes, predominant in the Italian health system, involve collecting clinical evidence and lead to payment only for patients responding to the new therapy.
"The emotive nature of cancer makes it difficult for health agencies to resist calls for reimbursement of even extremely expensive drugs with marginal efficacy," said Dr Garattini. "While performance-based schemes are not without political appeal, they contribute little to robust clinical assessment in practice. Simple financial-based contracts seem more efficient as a means for health services to reduce outlay on costly anti-cancer drugs and achieve access for patients."
However, the financial arrangements between pharmaceutical manufacturers and the health systems paying for the new drugs are kept commercial-in-confidence, leading the authors to conclude that when market-access agreements lead to prices which are not transparent, the schemes simply penalise those countries which rely on external reference pricing. "This lack of transparency raises an issue of public interest on the international level," said Dr Garattini.
INFORMATION:
Notes to editors
Market-access agreements for anti-cancer drugs (DOI: 10.1177/0141076814559626:) by Katelijne van de Vooren, Alessandro Curto, Nick Freemantle and Livio Garattini will be published by the Journal of the Royal Society of Medicine at 00:05hrs (UK) time Tuesday 9 December 2014.
For further information or a copy of the paper please contact:
Rosalind Dewar
Media Office, Royal Society of Medicine
DL +44 (0) 1580 764713
M +44 (0) 7785 182732
media@rsm.ac.uk
The JRSM is the flagship journal of the Royal Society of Medicine and is published by SAGE. It has full editorial independence from the RSM. It has been published continuously since 1809. Its Editor is Dr Kamran Abbasi.
SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC. http://www.sagepublications.com
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-09
Donald Trump's ego may be the size of his financial empire, but that doesn't mean he's the picture of mental health. The same can be said about the self-esteem of people who are living from paycheck to paycheck, or unemployed. New research from the University of California, Berkeley, underscores this mind-wallet connection.
UC Berkeley researchers have linked inflated or deflated feelings of self-worth to such afflictions as bipolar disorder, narcissistic personality disorder, anxiety and depression, providing yet more evidence that the widening gulf between rich and ...
2014-12-09
The combined use of spraying insecticide inside homes and insecticide-treated bed nets is no better at protecting children against malaria than using bed nets alone, a study in The Gambia suggests. The findings, published in The Lancet, should encourage donors to invest their limited resources in additional bed nets, the more cost-effective solution to tackling malaria*.
Lead author Professor Steve Lindsay, a disease ecologist at Durham University in the UK explains, "Our findings do not support any universal recommendation for indoor residual spraying as an addition ...
2014-12-09
The mass die-off of nerve cells in the brains of people with Alzheimer's disease may largely occur because an entirely different class of brain cells, called microglia, begin to fall down on the job, according to a new study by researchers at the Stanford University School of Medicine.
The researchers found that, in mice, blocking the action of a single molecule on the surface of microglia restored the cells' ability to get the job done -- and reversed memory loss and myriad other Alzheimer's-like features in the animals.
The study, to be published online Dec. 8 in ...
2014-12-09
1. Breast density notification laws substantially increase costs yet save few lives
Laws requiring women to be notified of their breast density so that they may discuss supplemental screening options, including ultrasound, with their health care providers would substantially increase costs and save relatively few lives, according to an article published in Annals of Internal Medicine. More than 40 percent of women between the ages of 40 and 74 have dense breast tissue, which puts them at increased risk for breast cancer and affects how well a mammogram can detect abnormalities. ...
2014-12-09
In the most comprehensive look yet at the safety of abortion, researchers at UC San Francisco have concluded that major complications are rare, occurring less than a quarter of a percent of the time, about the same frequency as colonoscopies.
The study, published online on Monday, Dec. 8, 2014, in Obstetrics & Gynecology, analyzed data from more than 50,000 women enrolled in the Medi-Cal fee-for-service program who obtained abortions from 2009 to 2010, and looked for complications that occurred within six weeks of the procedure.
The rate is similar to what has been ...
2014-12-09
Glucose is a component of carbohydrates, and the main energy source used by brain cells.
By studying rats, a team at Imperial College London identified a mechanism that appears to sense how much glucose is reaching the brain, and prompts animals to seek more if it detects a shortfall.
The researchers believe it may play a role in driving our preference for sweet and starchy foods.
The study, funded by the Biotechnology and Biological Sciences Research Council, is published in the Journal of Clinical Investigation.
Dr James Gardiner, from the Department of Medicine, ...
2014-12-09
Patients with plasma cell dyscrasis have high amounts of an abnormal immunoglobulin, called a paraprotein, in their blood. While many patients have no outward symptoms, paraproteins can impair immune function, thicken blood, and damage organs. Plasma cell dyscrasis may be inherited, but risk factors for this disease are poorly understood. A new study in the Journal of Clinical Investigation suggests that the presence of a modified host protein is associated with plasma cell dyscrasis risk. Michael Pfreundschuh and colleagues evaluated paraproteins in blood from patients ...
2014-12-09
Glucose is the primary fuel for the brain. Therefore, it has been proposed that the brain must sense glucose and promote eating behaviors when levels are low. A new study in the Journal of Clinical Investigation reveals that activation of an enzyme, glucokinase, in a region of the hypothalamus called the arcuate nucleus specifically increases glucose uptake. Steve Bloom and colleagues at Imperial College London determined that glucokinase levels in the arcuate nucleus are dramatically increased in fasted rats. In their rodent models, activation of glucokinase in the acruate ...
2014-12-09
Saturn's largest moon, Titan, is one of the few solar system bodies - and the only planetary moon - known to have fields of wind-blown dunes on its surface. (The others are Venus, Earth and Mars.)
New research, using experimental results from the high-pressure wind tunnel at Arizona State University's Planetary Aeolian Laboratory, has found that previous estimates of how fast winds need to blow to move sand-size particles around on Titan are about 40 percent too low.
A team of scientists led by Devon Burr of the University of Tennessee, Knoxville reported the findings ...
2014-12-09
An enormous spectrum of light streams from the sun. We're most familiar with the conventional visible white light we see with our eyes from Earth, but that's just a fraction of what our closest star emits. NASA regularly watches the sun in numerous wavelengths because different wavelengths provide information about different temperatures and processes in space. Looking at all the wavelengths together helps to provide a complete picture of what's occurring on the sun over 92 million miles away - but no one has been able to focus on high energy X-rays from the sun until recently.
In ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pricing for new drugs lacks transparency
